Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
Mingguang Li1, Zoi Panagi2, Konstantinos Avgoustakis2, Joshua Reineke11Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA; 2Pharmaceutical Technology Laboratory, Department of Pharmacy, University of Patras, Rion,...
Main Authors: | Avgoustakis K, Li M, Panagi Z, Reineke J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/physiologically-based-pharmacokinetic-modeling-of-plga-nanoparticles-w-a9429 |
Similar Items
-
Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
by: Liu XJ, et al.
Published: (2017-07-01) -
Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis
by: Zhou L, et al.
Published: (2015-08-01) -
Developing a highly stable PLGA-mPEG nanoparticle loaded with cisplatin for chemotherapy of ovarian cancer.
by: Lihua Cheng, et al.
Published: (2011-01-01) -
mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
by: Emanuela Fabiola Craparo, et al.
Published: (2021-09-01) -
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
by: Rafiei P, et al.
Published: (2017-01-01)